Related Experiment Video

Updated: Jun 2, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Harnessing synthetic lethal interactions in anticancer drug discovery

Denise A Chan1, Amato J Giaccia

  • 1Department of Radiation Oncology, University of California, San Francisco, California 94143-1331, USA.

Nature Reviews. Drug Discovery
|May 3, 2011
PubMed

Insights

Synthetic lethality screening identifies cancer-specific vulnerabilities. This approach exploits mutations present in tumors but not normal cells to develop targeted cancer therapies, offering selective cancer cell killing opportunities.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Targeted cancer therapies aim to exploit unique tumor features.
  • Synthetic lethality is a promising strategy for selective cancer cell killing.

Purpose of the Study:

  • To summarize strategies for identifying synthetic lethal interactions.
  • To review examples of synthetic lethal interactions in preclinical and clinical studies.
  • To discuss challenges in developing synthetic lethality-based therapies.

Main Methods:

  • Review of synthetic lethality screening strategies.
  • Analysis of preclinical and clinical studies on targeted anticancer therapies.
  • Discussion of challenges and future directions.

Main Results:

  • Synthetic lethality involves genetic interactions where combined mutations cause cell death.
  • This approach can selectively target cancer cells lacking specific mutations.
  • Numerous synthetic lethal interactions are under investigation for drug discovery.

Conclusions:

  • Synthetic lethality offers a powerful platform for targeted anticancer drug discovery.
  • Further research is needed to overcome challenges and realize the full potential of these therapies.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...